Roche's port­fo­lio 're­ju­ve­na­tion' fu­els 9% in­crease in drug sales, led by eye treat­ment

Roche re­port­ed a 9% in­crease in phar­ma sales dur­ing the first quar­ter, with ex­ec­u­tives chalk­ing up the bump to “re­ju­ve­na­tion” in its phar­ma­ceu­ti­cal port­fo­lio that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER